149 related articles for article (PubMed ID: 15721735)
1. Coronary vasospasm leading to an acute myocardial infarction after the administration of dolasetron.
Arole A; Kroll HR; Brown M
J Clin Anesth; 2005 Feb; 17(1):72-4. PubMed ID: 15721735
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine3 receptor antagonists.
Navari RM; Koeller JM
Ann Pharmacother; 2003 Sep; 37(9):1276-86. PubMed ID: 12921512
[TBL] [Abstract][Full Text] [Related]
3. [Value of dolasetron mesilate in treatment of postoperative nausea and vomiting].
Badaoui R; Yagoubi A; Carpentier F; Riboulot M; Ossart M
Presse Med; 2000 May; 29(17):947. PubMed ID: 10855246
[No Abstract] [Full Text] [Related]
4. Dolasetron and peri-operative cardiac arrhythmia.
Higgins DJ; Bunker NJ
Anaesthesia; 2005 Sep; 60(9):936-7; discussion 937-8. PubMed ID: 16115265
[No Abstract] [Full Text] [Related]
5. Dolasetron for prevention of nausea and vomiting due to cancer chemotherapy.
Med Lett Drugs Ther; 1998 May; 40(1026):53-4. PubMed ID: 9599596
[No Abstract] [Full Text] [Related]
6. Dolasetron-induced torsades de pointes.
Turner S; Mathews L; Pandharipande P; Thompson R
J Clin Anesth; 2007 Dec; 19(8):622-5. PubMed ID: 18083478
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous multivessel coronary vasospasm leading to cardiogenic shock.
Bromberg-Marin G; Mahmud E; Tsimikas S
J Invasive Cardiol; 2007 Apr; 19(4):E85-8. PubMed ID: 17404410
[TBL] [Abstract][Full Text] [Related]
8. Coronary vasospasm and atrial fibrillation associated with ondansetron therapy.
Havrilla PL; Kane-Gill SL; Verrico MM; Seybert AL; Reis SE
Ann Pharmacother; 2009 Mar; 43(3):532-6. PubMed ID: 19261954
[TBL] [Abstract][Full Text] [Related]
9. Dolasetron overdose resulting in prolonged QTc interval and severe hypotension: a case report and literature review.
Rochford M; Kiernan TJ; Aziz A
Emerg Med J; 2007 Jul; 24(7):515-7. PubMed ID: 17582056
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled, dose-ranging safety evaluation of single-dose intravenous dolasetron in healthy male volunteers.
Hunt TL; Cramer M; Shah A; Stewart W; Benedict CR; Hahne WF
J Clin Pharmacol; 1995 Jul; 35(7):705-12. PubMed ID: 7560251
[TBL] [Abstract][Full Text] [Related]
11. Myocardial infarction induced by coronary vasospasm after self-administration of epinephrine.
Saff R; Nahhas A; Fink JN
Ann Allergy; 1993 May; 70(5):396-8. PubMed ID: 8498731
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and safety of single intravenous and oral doses of dolasetron mesylate in healthy women.
Keung AC; Landriault H; Lefebvre M; Gossard D; Dempsey EE; Juneau M; Dimmitt D; Castles M; Roberts L; Spenard J
Biopharm Drug Dispos; 1997 May; 18(4):361-9. PubMed ID: 9158883
[TBL] [Abstract][Full Text] [Related]
13. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
Rubenstein EB
Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
[TBL] [Abstract][Full Text] [Related]
14. Is dolasetron the only possible culprit?
Pivalizza EG
J Clin Anesth; 2008 Sep; 20(6):478. PubMed ID: 18929294
[No Abstract] [Full Text] [Related]
15. Coronary vasospasm-induced acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease.
Hung MJ; Cheng CW; Yang NI; Hung MY; Cherng WJ
Int J Cardiol; 2007 Apr; 117(1):37-44. PubMed ID: 16844245
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of aprepitant on hydrodolasetron pharmacokinetics in CYP2D6 extensive and poor metabolizers.
Li SX; Pequignot E; Panebianco D; Lupinacci P; Majumdar A; Rosen L; Ahmed T; Royalty JE; Rushmore TH; Murphy MG; Petty KJ
J Clin Pharmacol; 2006 Jul; 46(7):792-801. PubMed ID: 16809805
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
Jones E; Koyama T; Ho RH; Kuttesch J; Shankar S; Whitlock JA; Cartwright J; Frangoul H
Pediatr Blood Cancer; 2007 Mar; 48(3):330-2. PubMed ID: 16304666
[TBL] [Abstract][Full Text] [Related]
18. Acute myocardial infarction with sumatriptan: a case report and review of the literature.
Chalaupka FD
Headache; 2009 May; 49(5):762-4. PubMed ID: 19456882
[TBL] [Abstract][Full Text] [Related]
19. Effect of infusion rate on the pharmacokinetics and tolerance of intravenous dolasetron mesylate.
Dimmitt DC; Hunt TL; Spalitto AJ; Cramer MB; Shah AK; Arumugham T; Hahne W
Ann Pharmacother; 1998 Jan; 32(1):39-44. PubMed ID: 9475818
[TBL] [Abstract][Full Text] [Related]
20. Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
Miller DR
Can J Anaesth; 2003 Mar; 50(3):215-20. PubMed ID: 12620941
[No Abstract] [Full Text] [Related]
[Next] [New Search]
